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Spectral entropyAbstract Background: Intravenous (IV) paracetamol has a signiﬁcant opioid-sparing effect. We
investigated the effect of paracetamol infusion on sevoﬂurane consumption during entropy moni-
tored general anesthesia.
Methods: Sixty-two ASA I and II patients undergoing thyroidectomy under general anesthesia
were included in a prospective, randomized, double-blind and placebo controlled study. The
patients were randomized to receive a slow infusion of either 1 g paracetamol (paracetamol group,
n= 31) or saline (control group, n= 31) just before induction of anesthesia. Sevoﬂurane concen-
tration was titrated to keep the state entropy value between 40 and 50. End-tidal sevoﬂurane con-
centration, sevoﬂurane consumption, recovery characteristics, time to ﬁrst analgesic request and
meperidine consumption during the ﬁrst 6 postoperative hours were recorded.
Results: The mean ± SD estimated sevoﬂurane consumption was signiﬁcantly lower in the para-
cetamol treated patients (36.2 ± 15 vs 44.9 ± 13.9 ml, in the control group; p= 0.021). Patients
receiving paracetamol had a faster post-anesthetic recovery proﬁle (extubation time, time to eye
opening to command and time to state name and mention his/her home address) than the other
116 W.M. Abdelmageed, W.M. Al Tahergroup (p< 0.05). Mean ± SD time to ﬁrst analgesic request was signiﬁcantly prolonged in paracet-
amol group compared to control group (48.4 ± 14.0 vs 40.7 ± 11.5 min, respectively; p= 0.021).
Meperidine consumption was higher in control group than in paracetamol group (28.7 ± 10.2 vs
23.1 ± 9.0 mg, respectively; p= 0.025).
Conclusion: Preoperative IV paracetamol infusion improved consumption and emergence from
entropy monitored sevoﬂurane anesthesia with enhancement of the early postoperative analgesia.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Open access under CC BY-NC-ND license.1. Introduction
Proper monitoring of the depth of anesthesia is crucial for
judicious titration of anesthetics to prevent awareness under
general anesthesia as well as the side effects of anesthetic
over-dose with the subsequent economic waste and environ-
mental pollution. With awareness, the patient may exhibit
symptoms ranging from mild anxiety to post traumatic stress
disorder (sleep disturbances, nightmares and social difﬁculties)
[1]. In the standard clinical practice, the depth of anesthesia is
judged by the clinical experience of the anesthetist, based on
the patient’s vital signs and the hemodynamic responses. How-
ever, the regular use of certain medications as b-blockers and
antihypertensive drugs render the hemodynamic signs unreli-
able for titration of anesthetics [2].
At present; the electroencephalogram (EEG) based spectral
entropy is increasingly being used for monitoring the depth of
anesthesia and provides information regarding the cortical
state of the patient and the level of hypnosis [3] as well as an
indirect measure of the adequacy of analgesia [4]. The monitor
uses different algorithms to calculate the level of consciousness
index by processing the EEG signal measured over the fore-
head and drive the numeric index [5]. The spectral entropy
has 2 signals: State entropy (SE) which reﬂects the hypnotic le-
vel of the patient; computed from an EEG data from the pre-
vious 15 s in the range of 0.8–32 Hz, and shows the value in the
range of 0–91 and Response entropy (RE) that includes; in
addition to the EEG, a forehead muscle electromyography
component and reﬂects the patient arousal and response to
painful stimuli. The latter is computed from an EEG data in
the range of 0.8–47 Hz and shows the value in the range of
0–100 [6]. State entropy values between ‘‘40–60’’ are the rec-
ommended surgical level of anesthesia while ‘‘100’’ signiﬁes
awake state and ‘‘0’’ indicates suppression of the cortical neu-
ronal activity [7].
Intravenous (IV) paracetamol (acetaminophen in USA) is
an effective analgesic and antipyretic agent acting at both the
central and peripheral components of the pain pathway [8]
and devoid of the detrimental effects of opioids and non-ste-
roidal anti-inﬂammatory drugs (NSAID) with a tolerability
proﬁle similar to placebo [9]. The onset of paracetamol analge-
sia starts rapidly after 5–10 min of IV administration, with
peak effect obtained within 1 h and lasting 4–6 h. [10] Thus,
IV paracetamol is a suitable medication for the treatment of
postoperative pain when used either alone or as a part of a bal-
anced analgesic regimen. Moreover, several studies in the med-
ical literature have demonstrated the opioid-sparing effect of
IV paracetamol [11–15]. In view of these reports; we hypothe-
sized that preoperative infusion of IV paracetamol would
decrease sevoﬂurane consumption during general anesthesia.
To explore this; we designed a prospective, randomized,double-blind and placebo controlled study to evaluate the
effect of the preoperative single-dose administration of IV
paracetamol on sevoﬂurane consumption in patients undergo-
ing thyroidectomy under general anesthesia with an entropy
added to the standard intraoperative monitors.
2. Methods
This study took place in king Abdulaziz Naval Base Hospital,
Jubail, Kingdom of Saudi Arabia, from May 2011 to April
2013. The protocol was approved by the Hospital Ethics
Committee and written informed consent was obtained from
each patient. The study was registered at the Australian New
Zealand Clinical Trial Registry (ANZCTR). URL and unique
identiﬁcation number: http://www.ANZCTR.org.au/ACT-
RN12613000485730.aspx. We studied 62 ASA physical status
I and II patients of both sex, aged 20–55 years scheduled for
subtotal thyroidectomy under general anesthesia. All enrolled
patients were euthyroid. Patients were excluded if they had
known allergy to paracetamol, neurological or psychological
diseases, impaired liver functions (Alanine Transami-
nase > twice the normal value) and impaired renal function
(serum creatinine >2.0 mg%). Exclusion criteria also included
pregnancy and breast feeding, the chronic use of analgesics or
drugs affecting the central nervous system (CNS) function, the
use of paracetamol within 6 h or any other analgesic medica-
tion within 12 h before the operation.
The patients were premedicated with lorazepam 2 mg orally
on the evening of operation, and had been fasting for 8 h
before surgery. At the operating theatre, all patients had a
venous cannula inserted into one of the veins of the dorsum
of the hand and IV ﬂuid (lactated Ringer’ solution) started
at a rate of 7 ml kg h1. Intraoperative vitals monitoring [elec-
trocardiogram (ECG), noninvasive systolic and diastolic blood
pressure (Systolic and Diastolic BP), peripheral oxygen satura-
tion (SpO2) were applied. After wiping the skin with alcohol,
the entropy sensor (Entropy sensor, Disposable. Datex-Ohme-
da, Instrumentarium Corp. Helsenki, Finland) was applied to
the patient’s forehead (approximately 4 cm above the nose)
and the temple area (between the corner of the eye and the
hairline). The sensor was connected to the Datex-Ohmeda
M-Entropy module via the Datex-Ohmeda ENT-3 Entropy
sensor cable.
Before the start of anesthesia, the patients were random-
ized, by using a computer generated random list to one of
two groups; the Paracetamol group (Group P) and the Control
group (Group C). All patients received a slow IV infusion over
15 min just before induction of anesthesia of either 1 g paracet-
amol (Perfalgan 10 mg ml1, 100 ml vial; UPSA, France)
(Group P, n= 31) or 100 ml of normal saline (Group C,
n= 31). Blinding was carried out by a technician, not involved
Preoperative paracetamol infusion reduces sevoﬂurane consumption during 117in the data collection, who made up identical infusions of par-
acetamol and 0.9% normal saline in equal volumes under ster-
ile conditions. Anesthesia was induced with fentanyl
1.5 lg kg1 and propofol 1 mg kg1. Tracheal intubation was
facilitated with atracurium 0.5 mg kg1. Oxygen and nitrous
oxide mixture (40:60% respectively) with sevoﬂurane 1.5 vol-
ume% in 3 L min1 fresh gas ﬂow were used for maintenance
of anesthesia. Sevoﬂurane concentration was titrated by 0.5
volume% every 5 min to allow the SE value to range between
40–50. However, when the hemodynamic parameters could not
be maintained (hypotension or bradycardia which were deﬁned
as a 30% reduction of the baseline values); vasoactive drugs
were used as indicated according to the usual clinical practice.
The patients were also monitored for signs of inadequate
anesthesia during surgery (tachycardia and hypertension
[30% increases from baseline values], pupillary dilatation, lac-
rimation, sweating, grimacing, movement, eye opening or
coughing) which were managed by increasing sevoﬂurane
concentration. Intermittent doses of atracurium to maintain
muscle relaxation were given to a single twitch of the train
of four and mechanical ventilation started with respiratory
rate 12 min1 and tidal volume 5–7 ml kg1 to keep the end ti-
dal carbon dioxide (ETCo2) at 30–35 mmHg. Intraoperative
vital data (ECG, heart rate [HR], Systolic and Diastolic PB,
SpO2 and the end-tidal sevoﬂurane concentration [sevoﬂu-
raneET]) were recorded by an anesthesia technician not aware
of the treatment groups; immediately after endotracheal
intubation, at 5 min intervals throughout the ﬁrst operative
hour, at the start of skin closure and on completion of surgery.
After application of the surgical dressing, sevoﬂurane
administration was stopped, and atropine 10 lg kg1 and neo-
stigmine 50 lg kg1 were used to antagonize the residual neu-
romuscular block. The trachea was extubated after recovery of
adequate spontaneous ventilation. Extubation time, time to
eye opening to command, time to state his/her name and time
to correctly mention his/her home address (assessed at 60 s
intervals) were noted and taken from cessation of sevoﬂurane
inhalation. Sevoﬂurane consumption was estimated for each
patient by the ‘‘vaporizer weighing method’’ in which the
vaporizer was ﬁlled to maximum and weighed using a sensitive
balance (Triple Beam Balance 700/800 Series, OHaus Corpo-
ration, Florham Park, N.J. 07932, USA) before induction of
anesthesia, then reweighed again at the completion of surgery.
By knowing the speciﬁc weight of sevoﬂurane (1.52 kg L1)
[16]; the volume of the consumed liquid sevoﬂurane was
estimated.
Following surgery, the patients were transferred to the post
anesthesia care unit (PACU) where they were monitored and
received oxygen via a face mask at 6 L min1. Pain intensity
was assessed immediately by the nurses who were blinded to
the treatment group using a 10-cm visual analogue scale
(VAS) on which 0-cm indicated no pain and 10-cm the worst
imaginable pain and was re-assessed again in the surgical
ward, every 2 h till the end of the 6th postoperative hour.
Meperidine IV bolus 20 mg was administered when the VAS
>3 or when requested by the patient and could be repeated
every 10 min until VAS is 3 or less, with a maximum dose
not more than 1 mg/kg. Time to the ﬁrst analgesic demand (de-
ﬁned as the period between tracheal extubation to the ﬁrst
administration of analgesic medication) was recorded. Total
doses of meperidine given in the PACU and surgical ward were
calculated. If pain scores remained >3 more than 30 min; IVlornoxicam 8 mg was used as a rescue analgesic and could be
repeated once more after a lockout time of 1 h.
The degree of sedation was recorded on admission to the
PACU and at the 2nd, 4th and 6th postoperative hour using
a four-points scale: 0 = awake and alert, 1 = drowsy,
2 = mostly sleeping, 3 = difﬁcult or impossible to awaken.
The frequency and severity of postoperative nausea and
vomiting (PONV) were observed and documented; with no dif-
ferentiation had been made between retching and vomiting till
the end of the 6th postoperative hour as follows: 0 = no nau-
sea, 1 = mild-moderate nausea, 2 = mild vomiting (once per
observational period) with severe nausea, 3 = moderate vom-
iting (twice per observation period), 4 = severe vomiting (3–4
times per observation period). For moderate and severe vom-
iting, ondansetron 4 mg IV injection was used as a rescue
antiemetic.
Other side effects including bradycardia, hypotension, respi-
ratory depression (persistent respiratory rate <10 breaths
min1 or oxygen saturation<90%without oxygen supplemen-
tation), headache, malaise, anxiety, muscle spasm and adverse
reactions at the injection site (pain, burning sensation, erythema
and pruritus) were recorded for each patient, and suitable
treatment was given if indicated. The next day of surgery, the
patients were questioned about having nightmares or dreams
and whether they could recall any intraoperative event.
3. Statistical methods
The required sample size was calculated using G\Power soft-
ware version 3.1.3 (Heinrich Heine Universita¨t, Institut fu¨r
Experimentelle Psychologie, Du¨sseldorf, Germany). The pri-
mary outcome measure was the difference in end-tidal sevoﬂu-
rane between the two study groups. It was estimated that a
sample of 30 patients in each study group would achieve a
power of 81% to detect a medium effect size (d) of 0.35 as re-
gards the primary outcome measure using a two-sided un-
paired t test and setting the type I error at 0.05.
Statistical analysis was done on a personal computer using
GraphPadª Prismª version 6.01 (GraphPadª Software Inc.,
La Jolla, California, USA). Numerical data are presented as
mean (SD) and intergroup differences are compared with the
independent-samples t test. Categorical data are presented as
ratio or as number (%) and between-group differences are
compared using the Pearson chi square test or the chi square
test for trends for nominal or ordinal data, respectively. Fish-
er’s exact test is used in place of the chi square test if >20% of
cells in any contingency table had an expected count of <5.
A two-side P< 0.05 is considered statistically signiﬁcant.
4. Results
All patients completed the study. The patients’ characteristics
were comparable in the 2 groups. There were no statistical dif-
ferences between both groups in the mean baseline values of
the hemodynamic and respiratory parameters. The duration
of surgery and anesthesia was similar in the studied groups
(Table 1).
Intraoperative hemodynamic monitoring revealed no sig-
niﬁcant differences in the 2 groups (p> 0.05) and no patient
received vasoactive drugs for hemodynamic instability. There
were statistically signiﬁcant differences in the post-anesthetic
Table 1 Patient characteristics and operative data.
Variable Group P (n= 31) Group C (n= 31) P value
Age (year) 32.2 (3.4) 31.9 (3.1) 0.718
Gender (male/female) 3/28 2/29 1.0
Weight (kg) 65.2 (4.7) 64.9 (4.1) 0.790
Height (cm) 160.9 (5.5) 162.7 (5.6) 0.207
ASA-PS (I/II) 29/2 27/4 0.671
Duration of surgery (min) 103.1 (14.1) 105.7 (12.9) 0.452
Duration of anesthesia (min) 122.6 (4.9) 120.0 (5.4) 0.052
Baseline heart rate (beats/min) 63 (8.0) 65 (9.0) 0.359
Baseline systolic BP (mmHg) 114 (11.0) 117 (14.0) 0.352
Baseline diastolic BP (mmHg) 66.7 (6.0) 68 (4.0) 0.320
Data are presented as mean (SD) or ratio.
Statistical signiﬁcance at p< 0.05.
Table 2 Estimated sevoﬂurane consumption and post-anesthetic recovery proﬁle.
Variable Group P (n= 31) Group C (n= 31) P value
Estimated sevoﬂurane consumption (ml) 36.2 (15.0) 44.9 (13.9) 0.021
Extubation time (min) 6.1 (2.9) 7.9 (3.5) 0.031
Time to eye opening (min) 8.2 (2.8) 9.8 (3.2) 0.040
Time to state name (min) 10.4 (2.3) 12.6 (4.5) 0.018
Time to mention home address (min) 12.2 (4.1) 14.8 (4.9) 0.027
Data are resented as mean (SD).
Statistical signiﬁcance at p< 0.05.
Figure 1 Mean end-tidal sevoﬂurane concentration in both
study groups. Error bars represent SD. ET060: End-tidal sevo-
ﬂurane concentration at 0–60 min after endotracheal intubation.
ETSC: End-tidal sevoﬂurane concentration at skin closure. ETEND:
End-tidal sevoﬂurane concentration at the end of surgery.
Figure 2 Mean postoperative pain scores in the two study
groups. Error bars represent SD.
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mand, time to state name and time to correctly mention his/her
home address) between the paracetamol group and the control
group (Table 2). There was a statistically signiﬁcant difference
in end-tidal values of sevoﬂurane concentration in group P
compared to group C (p< 0.05). SevoﬂuraneET values were
higher in the control group during the time periods from
15 min after endotracheal intubation till the end of surgery
(Fig. 1). The mean ± SD estimated sevoﬂurane consumption
during surgery was signiﬁcantly lower in the paracetamolgroup than in the control group (36.2 ± 15 vs 44.9 ±
13.9 ml, respectively; p= 0.021) (Table 2).
The VAS scores of the patients in the control group were
signiﬁcantly higher than those in the paracetamol group on
admission to the PACU (p= 0.018) and were similar in the
2 groups thereafter (Fig. 2). The mean ± SD time to ﬁrst anal-
gesic request was signiﬁcantly prolonged in the paracetamol
group compared to the control group (48.4 ± 14.0 vs
40.7 ± 11.5 min, respectively; p= 0.021). Analysis of meperi-
dine consumption in the PACU and the surgical ward during
the ﬁrst 6 postoperative hours revealed a statistically signiﬁ-
cant difference between the 2 groups. The mean ± SD meper-
idine consumption was higher in the control group than in the
Table 3 Postoperative analgesia.
Variable Group P (n= 31) Group C (n= 31) P value
Time to ﬁrst analgesic request (min) 48.4 (14.0) 40.7 (11.5) 0.021
Total meperidine consumption (mg) 23.1 (9.0) 28.7 (10.2) 0.025
Need for rescue analgesic (%) 13 (41.9) 18 (58.1) 0.310
Total lornoxicam consumption (mg) 4.9 (1.2) 5.7 (1.4) 0.019
Data are presented as mean (SD) or number (%).
Statistical signiﬁcance at p< 0.05.
Table 4 Incidence of PONV during the ﬁrst 6 postoperative hours.
PONV score Group P (n= 31) Group C(n= 31) P value
No nausea 15 (48.4) 11 (35.5) 0.337
Mild-to-moderate nausea 8 (25.8) 9 (29)
Severe nausea, mild vomiting 4 (12.9) 6 (19.4)
Moderate vomiting 3 (9.7) 3 (9.7)
Severe vomiting 1 (3.2) 2 (6.5)
Data are presented as number (%).
Statistical signiﬁcance at p< 0.05.
Table 5 Postoperative sedation scores.
Time Sedation score Group P (n= 31) Group C (n= 31) P value
Admission to PACU 0 23 (74.2%) 24 (77.4%) 0.845
1 5 (16.1%) 4 (12.9%)
2 3 (9.7%) 3 (9.7%)
2 h after surgery 0 26 (83.9%) 17 (54.8%) 0.046
1 3 (9.7%) 11 (35.5%)
2 2 (6.5%) 3 (9.7%)
4 h after surgery 0 28 (90.3%) 23 (74.2%) 0.147
1 2 (6.5%) 6 (19.4%)
2 1 (3.2%) 2 (6.5%)
6 h after surgery 0 30 (96.8%) 27 (87.1%) 0.165
1 1 (3.2%) 4 (12.9%)
Data are presented as number (%).
Statistical signiﬁcance at p< 0.05.
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tively; p= 0.025). In addition, 18 patients (58%) in the control
group received rescue analgesia compared to 13 patients (42%)
in the paracetamol group (p= 0.31), with a statistically signif-
icant difference between both groups in the mean ± SD cumu-
lative doses of lornoxicam used (4.9 ± 1.2 mg in group P vs
5.7 ± 1.4 mg in group C, p= 0.019) (Table 3).
There were no statistically signiﬁcant differences in the
postoperative mean HR and mean Systolic and Diastolic BP
(p> 0.05) between the studied groups. During the ﬁrst 6
postoperative hours; 2 (6.4%) patients in group P and 3 other
patients in group C (9.6%), developed oxygen desaturation in
the surgical ward with respiratory depression. They improved by
oxygen mask; Venturi 40%, 10 L min1, with a non-signiﬁcant
difference between the 2 groups (p> 0.05). Numerically, more
patients in the control group experienced PONV than those
receiving paracetamol, but this did not reach statistical signif-
icance (p= 0.337) (Table 4). There was no signiﬁcant differ-
ence between the groups regarding the mean sedation scores
on admission to the PACU (p> 0.05), but at the 2nd postop-
erative hour; the mean scores of sedation were signiﬁcantlylower in the paracetamol group with no signiﬁcant differences
between the studied groups thereafter till the end of the 6th
postoperative hour (Table 5). No patient in either group com-
plained of headache, muscle spasm or local adverse reactions
at site of the venous cannula and none of them noted recall
of intraoperative events or complained of having nightmares.
Ten patients in the paracetamol group (32.2%) and 8 in the
control group (25.8%) reported dreaming during sleep, with
no statistical signiﬁcance (p= 0.780).5. Discussion
The results of this study showed that IV administration of 1 g
paracetamol before induction of general anesthesia was associ-
ated with a signiﬁcant decrease in sevoﬂurane consumption
during surgery when spectral entropy was added to the
standard intraoperative monitoring. This intraoperative reduc-
tion in the volatile gas consumption had an impact on the
emergence from anesthesia and resulted in acceleration of the
post-anesthetic recovery times of the patients.
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alertness after completion of surgery is of particular impor-
tance for earlier maintenance of patent airway, better periphe-
ral oxygen saturation and more protection against pulmonary
aspiration. One approach to hasten post-anesthetic recovery is
the introduction of the short half-life volatile anesthetics as
sevoﬂurane and desﬂurane [16]. Sevoﬂurane has the desirable
advantage of a rapid elimination; due to its low solubility in
blood that results in a rapid fall in the alveolar anesthetic con-
centration upon discontinuation and a fast recovery from
anesthesia [17]. However, following cessation of sevoﬂurane
administration, complete awakening may require up to
90 min to occur, depending on the amount of residual sevoﬂu-
rane [16] and during that time; the protective airway reﬂexes
may not be restored. After sevoﬂurane discontinuation, its le-
vel decreases rapidly with a residual 10% persistence after 1 h,
and 0.5% tail which may last for the next 8 h. [18] Residual
sevoﬂurane; together with its degradation products, may lead
to impairment of the CNS chemosensetivity to hypoxia during
recovery [19] and prolongation of the neuromuscular block by
relaxants [20]. These effects could be of concern during the
post-anesthetic recovery of patients who are vulnerable to
postoperative respiratory complications.
The utilization of the EEG based monitors as the bispectral
index (BIS) and the spectral entropy for judging the depth of
general anesthesia and the level of hypnosis during surgery
has been shown to result in reduction of sevoﬂurane consump-
tion and shorten the recovery time. Pavlin and co-workers [21]
reported that the end-tidal sevoﬂurane concentration was re-
duced by 13% when BIS monitor was used to titrate the dose
of the volatile anesthetic. Aime and colleagues [22] demon-
strated that sevoﬂurane anesthesia using either BIS or an en-
tropy monitor to titrate the administered dose of anesthetics,
both monitoring methods equally reduced the administered
dose of sevoﬂurane by 29%. Although the recommended sur-
gical level of general anesthesia for entropy monitor lies be-
tween 40–60; we preferred in this study to be more
conservative and chose a lower target range of SE between
40–50; to ensure adequate level of hypnosis and to minimize
the risk of intraoperative awareness; as its occurrence is often
the direct consequence of using insufﬁcient doses of anesthetics
or light-anesthetic techniques; taking into consideration some
reports of failure of entropy monitor [23,24]. Also, we believe
that the use of the processed EEG based monitors to guide the
depth of anesthesia could be associated with intentional over-
reduction in the anesthetic depth on the basis of the displayed
values of these monitors. It is noteworthy that none of our pa-
tients noted recall of any intraoperative event, and only a few,
in either group, reported the usual dreaming while sleeping
during the ﬁrst postoperative night.
As far as our knowledge, this is the ﬁrst study in the med-
ical literature that tests the inﬂuence of preoperative IV para-
cetamol infusion on sevoﬂurane consumption during surgery
with spectral entropy monitoring. In this study, sevoﬂurane
consumption was reduced by 19.4% and this was associated
with rapid recovery from general anesthesia in the paracetamol
treated patients. Intravenous paracetamol is a non-opioid
analgesic and antipyretic, recommended world-wide as a ﬁrst
line treatment of pain and fever in adults and children [9]
although the precise mechanism of action is still unclear, the
agent induces analgesia via inhibition of the central and
peripheral cyclo-oxygenase I and II pathways that result inreduced synthesis of prostaglandin E2; one of the primary
mediator of nociception [25]. Another hypothesis assumes that
paracetamol analgesia is due to its direct inhibition of the N-
methyl-D-aspartate (NMDA) receptor, which stimulates sub-
stance P-dependent synthesis of nitric oxide, another primary
mediator of pain [26]. The central antinociceptive effect of par-
acetamol may involve the serotonergic system as well through
activation of the descending serotonergic pathways which are
part of the descending pain system in the dorsal horn of the
spinal cord [27]. This assumption was supported by the study
of Pickering et al. [28] who revealed that the antagonists of
5-hydroxytryptamine (5-HT3) receptor; namely tropisetron
and granisetron, completely blocked the analgesic effect of
paracetamol administered to male adult volunteers. One of
the mechanisms involved in the analgesic efﬁcacy of paraceta-
mol is its modulatory effect on endogenous cannabinoid sys-
tem [29]. The use of IV paracetamol for postoperative pain
control is gradually increasing and several studies in the liter-
ature have demonstrated the analgesic and the opioid-sparing
effect of this agent. Khan and his co-workers [29] in a study of
84 patients undergoing arthroscopic knee surgery showed that
patients receiving IV paracetamol had similar pain relief imme-
diately upon arrival in the recovery room and for the next 4 h,
compared with those treated with IV morphine. They came to
the conclusion that IV paracetamol 1 g was not signiﬁcantly
different from that of morphine 0.1 mg kg1. Sinatra et al.
[11] recorded a signiﬁcant reduction in morphine consumption
over 6 h following the infusion of a single dose of paracetamol
1gm for pain management after major orthopedic surgery.
Tsang and colleagues [30] noted a satisfactory pain relief to-
gether with a remarkable opioid-sparing effect in 47 preopera-
tive patients with traumatic hip fracture, who were given
regular doses of IV paracetamol. In a recent study involving
75 patients who underwent lower limb surgery under spinal
anesthesia, Khalili and his colleagues [31] compared the use
of a single IV infusion of paracetamol 15 mg kg–1 as a preemp-
tive analgesic (given half an hour preoperatively) or as a pre-
ventive analgesia (given prior to skin closure). They observed
that both preemptive and preventive paracetamol administra-
tions were effective, enhanced the postoperative analgesia
and reduced the need for rescue analgesics. Moreover, they
found that the total meperidine consumption at 24 h after sur-
gery was lowest in the patients received preemptive paraceta-
mol. In agreement with these trials, the patients receiving IV
paracetamol in the current study had improved postoperative
analgesia; in addition to their fast emergence from general
anesthesia. They had signiﬁcantly lower VAS scores on admis-
sion to the PACU compared to the control group and required
a lower cumulative amount of meperidine and lornoxicam,
which strongly supports the opioid-sparing effect of IV para-
cetamol. Furthermore, the patients treated with paracetamol
had better postoperative scores of sedation and PONV com-
pared to the control group, which could be attributed to their
lower consumption of IV meperidine throughout the early
postoperative period.
The onset of paracetamol analgesia after IV administration
occurs rapidly within 5–10 min [10]. Paracetamol does not
extensively bind to plasma protein and exhibits rapid penetra-
tion into the cerebrospinal ﬂuid, with peak analgesic effect
obtained within 1 h and the duration of its effect lasting for
approximately 4–6 h [8]. It has to be noted that the improve-
ment in pain scores and analgesic consumption in the current
Preoperative paracetamol infusion reduces sevoﬂurane consumption during 121study over the ﬁrst 6 postoperative hours was longer than ex-
pected and could not be attributed to the systemic effects of
just a single IV dose of paracetamol. Nevertheless, this pro-
longed paracetamol analgesia could be explained in terms of
preemptive analgesia; which enrolls the use of analgesics
and/or anesthetics before elicitation of painful stimuli to pre-
vent or reduce subsequent pain. Thus, if detection of painful
stimuli is prevented during surgery, the postoperative pain
should be minimized. We therefore, share the view of other
authors [31,32] that the preemptive treatment of postoperative
pain may substantially reduce the analgesic requirement after
surgery. Another possible explanation would be the potent
analgesic effect of the metabolite of paracetamol. The agent
is thought to inﬂuence the endogenous cannabinoid system
via an active metabolite (P-aminophenol) which is conjugated
with arachidonic acid by fatty acid amide hydrolase to form
AM404, (also known as N-arachidophenolamine) [33].
AM404 prevents the reuptake of the endogenous cannabinoids
like anandamide from the synaptic cleft [34]. This neurotrans-
mitter is an eicosanoid, synthesized on demand and expresses
agonistic activity at the cannabinoid receptors. At least 2 can-
nabinoids receptor types exist in the mammalian tissues, CB1
and CB2, and activation of these receptors appears to amelio-
rate pain and inﬂammation [35].
It has been suggested that supplementation of sevoﬂurane
anesthesia by continuous intraoperative infusion of remifenta-
nil resulted in reduction of the volatile gas consumption and
speeding up emergence from general anesthesia. Sert and his
colleagues [36] concluded that the use of low ﬂow sevoﬂurane
anesthesia combined with continuous intraoperative remifen-
tanil infusion during tympanoplasty resulted in a faster early
recovery and decreased sevoﬂurane consumption. Similarly,
Kim et al. [7] in a study of 40 females undergoing gynecolog-
ical surgery with entropy monitored general anesthesia, dem-
onstrated that the end-tidal sevoﬂurane concentration as well
as the total volatile gas consumption had been reduced by con-
tinuous intraoperative remifentanil infusion. We agree with
those authors [7,36] in the context that reducing the consump-
tion of the inhalational anesthetics without compromising
both the clinical outcome and the patient satisfaction is highly
desirable in order to facilitate earlier recovery from general
anesthesia and to minimize the environmental pollution and
the economic waste. In the present study, we used the spectral
entropy monitoring to titrate the sevoﬂurane concentration to
the desirable depth of anesthesia. Although remifentanil was
found to effectively decrease sevoﬂurane consumption; we
used the non-opioid analgesic paracetamol in our trial to re-
duce the volatile gas consumption during surgery. Remifenta-
nil is a selective lu-opioid receptor agonist that provides
intense analgesia of rapid onset and ultra-short duration and
is commonly used as a supplemental drug for general anesthe-
sia. [37] Nevertheless, being a lu-receptor agonist, the agent
has side effects as bradycardia, hypotension, respiratory
depression and PONV and due to its pharmacokinetic charac-
teristics, emergence from remifentanil-based anesthesia is very
rapid and can result in severe pain during the early postoper-
ative period [38]. On the other hand certain pharmacodynam-
ics and pharmacokinetics rendered IV paracetamol a favorable
choice for us to test its efﬁcacy in reducing volatile gas con-
sumption rather than remifentanil, namely its ease of adminis-
tration compared to that of remifentanil (as the continuous
intraoperative infusion of a medication is cumbersome), therare occurrence of side effects with a tolerability proﬁle similar
to placebo, and its ability to provide effective postoperative
analgesia. This last effect of paracetamol is of utmost impor-
tance as postoperative pain is the most common undesirable
outcome for patients undergoing surgical procedures and can
delay recovery from general anesthesia and prolong hospital
stay [39].
In conclusion, we demonstrated that the preoperative IV
paracetamol infusion improved consumption and emergence
from entropy-monitored sevoﬂurane anesthesia in patients
undergoing subtotal thyroidectomy, together with enhance-
ment of the early postoperative analgesia and reduction of res-
cue analgesics requirement. Further studies are needed to
conﬁrm these results in different surgeries.
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